Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by mkprovoson Jun 17, 2010 11:53am
630 Views
Post# 17198021

timeline

timeline

SSS has met every deadline per their schedule on the website home page.  They post their scheduled estimates and as long as I have been in this stock, they have met everyone of those targets and met some early. 

I think they were optimistic on the 2 to 3 weeks.  They were probably in the mode of figuring out what happened, and the timeline was the least worry.

According to the website, they have a schedule to have "Complete preclinical study for hemorrhagic stroke"

done in H2 of 2010  (for those of you that cannot figure out what the 'H' stands for it is "half" (second half) of 2010, that means anytime after the start of July).  If they get it done by the end of June they are still ahead of schedule.  Don't stress over it.  This was the actual timeline.  Obviously everything went panic with the Placebo doing well, but everything is still on a proper course.  This is how long things take.

Bullboard Posts